Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Sep 2020 · 1 min read
In brief
In brief
This study examines outcomes of implantable venous access device (port) placement in children with severe hemophilia at a tertiary pediatric institution. Ports are used when peripheral access is inadequate for clotting factor replacement therapy, but carry risks of complications in this population.
Written by the GCMD Library team from the article.
Background: Clotting factor replacement forms the pillar of treatment for children with hemophilia. Most children can be treated using peripheral venipuncture, but very young children and children with poor venous access might require a central venous catheter. Short-term and long-term complications of implantable venous access device placement (also known as port placement) can result in important morbidity and mortality in children with hemophilia.
Objective: The purpose of this study is to describe our experience with port placement in children and adolescents with severe hemophilia (